CGA contributes to the metabolism of glucose by promoting glucose uptake in both insulin‐sensitive and noninsulin‐sensitive adiposity (Gökcen & Şanlier, 2019) and also increases insulin secretion, decreases insulin tolerance, and activates or inhibits the body's enzyme activity to promote glucose metabolism, lowering blood glucose levels, and treating diabetes by reducing insulin tolerance (Jin et al., 2015). Here, INS is linked to diabetes mellitus.